1. riss155
2. mpat5123
3. dricherson
1.mpat5123 06/21/2018
Doses the first patient in the VOYAGER Phase 3 clinical trial
2.mpat5123 06/04/2018
JMP Securities sets PT at $103
3.riss155 08/01/2018
Beats EPS estimates by $0.70 and beats on revenues
4.riss155 04/16/2018
Blueprint Medicines Announces Proof-of-Concept Data for Highly Selective RET Inhibitor BLU-667 from Phase 1 ARROW Clinical Trial in Patients with RET-Altered Solid Tumors
5.riss155 06/04/2018
Blueprint Medicines and CStone Pharmaceuticals Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Avapritinib, BLU-554 and BLU-667 in Greater China
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW